Literature DB >> 4392189

Drug--interaction between sulthiame (Ospolot (R)) and phenytoin in the treatment of epilepsy.

O V Olesen, O N Jensen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4392189

Source DB:  PubMed          Journal:  Dan Med Bull        ISSN: 0907-8916


× No keyword cloud information.
  10 in total

1.  Interaction of phenytoin with chlorpheniramine.

Authors:  R N Pugh; A M Geddes; W B Yeoman
Journal:  Br J Clin Pharmacol       Date:  1975-04       Impact factor: 4.335

Review 2.  Pharmacokinetic drug interactions with phenytoin (Part II).

Authors:  R L Nation; A M Evans; R W Milne
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

Review 3.  Drug interactions that matter. A critical reappraisal.

Authors:  G T McInnes; M J Brodie
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

Review 4.  Anticonvulsant drugs. II. Clinical pharmacological and therapeutic aspects.

Authors:  H Kutt; S Louis
Journal:  Drugs       Date:  1972       Impact factor: 9.546

5.  Proceedings: Inhibition of phenytoin metabolism by sulthiame.

Authors:  G W Houghton; A Richens
Journal:  Br J Pharmacol       Date:  1973-09       Impact factor: 8.739

6.  Inhibition of phenytoin metabolism by sulthiame in epileptic patients.

Authors:  G W Houghton; A Richens
Journal:  Br J Clin Pharmacol       Date:  1974-02       Impact factor: 4.335

Review 7.  Pharmacokinetic interactions with antiepileptic drugs.

Authors:  E Perucca
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

Review 8.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

Review 9.  Drug interactions and clinical pharmacokinetics.

Authors:  M B Kristensen
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

10.  Phenytoin intoxication induced by sulthiame in epileptic patients.

Authors:  G W Houghton; A Richens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-03       Impact factor: 10.154

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.